On Thursday 23rd November, we hosted the Kinapse Brexit Summit at the Royal Society in London. About the Summit The aim of the summit was to facilitate round table discussion and debate with key players from industry and patient groups on the subject of Brexit and its potential impact on these [...]
After months of speculation, the EMA will take up operations at a site in Amsterdam by 30th March 2019. What does that mean for your organisation?
Having joined Kinapse in October, Adam Sherlock shares the reasons he chose us, and his hopes for the future of the business.
We are delighted to announce a new senior level Executive appointment based in our Indian operation. Learn why we're excited to have Hemant on board.
In this early phase, as the industry is gearing up to meet the regulatory requirement for lay summaries, industry leaders are divided over their approach.
We're launching redact360, an automated Clinical Trial redaction and anonymisation tool. redact360 has already delivered 19 successful client submissions.
